IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $3,500,000 | +18.7% | 179,946 | +1.6% | 0.01% | +16.7% |
Q4 2017 | $2,948,000 | -6.5% | 177,081 | +14.0% | 0.01% | -14.3% |
Q3 2017 | $3,153,000 | +28.2% | 155,306 | +1.7% | 0.01% | +16.7% |
Q2 2017 | $2,459,000 | +33.8% | 152,717 | +5.1% | 0.01% | +50.0% |
Q1 2017 | $1,838,000 | +29.5% | 145,324 | +35.7% | 0.00% | 0.0% |
Q4 2016 | $1,419,000 | -41.3% | 107,097 | +5.1% | 0.00% | -42.9% |
Q3 2016 | $2,416,000 | -12.2% | 101,925 | +6.7% | 0.01% | -12.5% |
Q2 2016 | $2,753,000 | -6.9% | 95,530 | +3.4% | 0.01% | -11.1% |
Q1 2016 | $2,957,000 | -22.9% | 92,346 | +3.0% | 0.01% | -25.0% |
Q4 2015 | $3,833,000 | +21.0% | 89,631 | -0.4% | 0.01% | +9.1% |
Q3 2015 | $3,169,000 | -20.2% | 90,001 | +4.1% | 0.01% | -15.4% |
Q2 2015 | $3,971,000 | -22.2% | 86,466 | -20.6% | 0.01% | -13.3% |
Q1 2015 | $5,104,000 | +51.9% | 108,906 | +2.6% | 0.02% | +50.0% |
Q4 2014 | $3,361,000 | +37.0% | 106,106 | +2.6% | 0.01% | +42.9% |
Q3 2014 | $2,453,000 | -21.7% | 103,452 | -1.0% | 0.01% | -22.2% |
Q2 2014 | $3,133,000 | +7.9% | 104,472 | -4.9% | 0.01% | 0.0% |
Q1 2014 | $2,904,000 | +1.9% | 109,908 | -3.1% | 0.01% | +12.5% |
Q4 2013 | $2,850,000 | +16.1% | 113,383 | -5.3% | 0.01% | 0.0% |
Q3 2013 | $2,455,000 | +7.6% | 119,703 | +4.6% | 0.01% | +14.3% |
Q2 2013 | $2,282,000 | – | 114,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |